Interleukin-22 from bench to bedside: a promising drug for epithelial repair

Cellular and Molecular Immunology - Tập 16 Số 7 - Trang 666-667 - 2019
Bin Gao1, Xiaogang Xiang1
1Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pan, H., Hong, F., Radaeva, S. & Gao, B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1, 43–49 (2004).

Tang K. Y., et al. Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects. Cell Mol Immunol 2018 Apr 18. doi: 10.1038/s41423-018-0029-8.

Xie, M. H. et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275, 31335–31339 (2000).

Dumoutier, L., Van Roost, E., Ameye, G., Michaux, L. & Renauld, J. C. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 1, 488–494 (2000).

Radaeva, S., Sun, R., Pan, H. N., Hong, F. & Gao, B. Interleukin-22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39, 1332–1342 (2004).

Sabat, R., Ouyang, W. & Wolk, K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat. Rev. Drug. Discov. 13, 21–38 (2014).

Dudakov, J. A., Hanash, A. M. & van den Brink, M. R. Interleukin-22: immunobiology and pathology. Annu. Rev. Immunol. 33, 747–785 (2015).

Park, O. et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54, 252–261 (2011).

Wolk, K. et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J. Mol. Med (Berl.) 87, 523–536 (2009).

Stefanich, E. G. et al. Preclinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases. Biochem. Pharmacol. 152, 224–235 (2018).

Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648–651 (2007).

Alabbas, S. Y., Begun, J., Florin, T. H. & Oancea, I. The role of IL-22 in the resolution of sterile and nonsterile inflammation. Clin. Transl. Immunol. 7, e1017 (2018).

Crabb, D. W. et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the niaaa alcoholic hepatitis consortia. Gastroenterology 150, 785–790 (2016).